07.01.2015 Views

APPLICANT - Imperial College London

APPLICANT - Imperial College London

APPLICANT - Imperial College London

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

patient samples. We have a number of fruitful collaborations with various other investigators<br />

working on areas to do with drug-resistance, signal transduction, genomic instability, DNA<br />

methylation and cell mitosis. Dr Chevassut also runs early phase clinical trials in AML<br />

through the Clinical Investigation Research Unit at the Royal Sussex County Hospital with<br />

five other consultant colleagues who collectively manage a busy level 2 haematology service<br />

and laboratory with in-house immunophenotyping facilities. Brighton has strong clinical and<br />

research links with King’s <strong>College</strong> Hospital and the Royal Marsden where we currently refer<br />

patients for autologous and allogeneic stem cell transplantation. Interested candidates are<br />

encouraged to look at the website for further details.<br />

http://www.bsms.ac.uk/research/oncology/tim_chevassut.htm<br />

Post 3 – Oncology– based at Royal Sussex County Hospital/BSMS<br />

CODE: BSMS/003<br />

F1<br />

F2<br />

Royal Sussex<br />

County Hospital/<br />

Princess Royal<br />

University<br />

Hospital<br />

Royal Sussex<br />

County Hospital/<br />

Princess Royal<br />

University<br />

Hospital<br />

Medical<br />

Assessment Unit<br />

Clinical Infectious<br />

Diseases<br />

4m General Surgery 4m General Internal<br />

Medicine/<br />

Respiratory<br />

4m<br />

General Internal<br />

Medicine<br />

4m<br />

4m Oncology 4m<br />

Both clinical and lab-based research projects are available. The Cancer in the Elderly<br />

Research Programme was developed in 2008 by Dr Alistair Ring to address the complex<br />

needs of the increasing number of older patients with cancer. Current projects are<br />

addressing such issues as fitness for cytotoxic chemotherapy, nutritional status, social<br />

support, biological markers of ageing and poly-pharmacy in older cancer patients. In<br />

addition, aspects of the epidemiology of cancer in the elderly and treatment preferences are<br />

being addressed in partnership with colleagues at the University of Sussex (Psychosocial<br />

Oncology Group) and BSMS Department of Epidemiology.<br />

The Chalmers laboratory at the Genome Damage and Stability Centre at the University of<br />

Sussex studies cellular responses to cytotoxic DNA damaging agents, with particular<br />

emphasis on glioblastoma multiforme. We are currently investigating the potential of<br />

inhibitors of DNA repair to promote tumour specific radio- and chemo-sensitisation. Previous<br />

research has led to a phase I clinical trial of the PARP inhibitor olaparib in recurrent<br />

glioblastoma multiforme. The lab offers an ideal environment for an academic F2 project to<br />

acquire experience in translational laboratory science. The candidate will be trained in cell<br />

culture techniques and a range of assays studying induction and repair of DNA damage.<br />

http://www.bsms.ac.uk/research/oncology/anthony_chalmers.htm<br />

Post 4 – Nuclear Medicine – based at Royal Sussex County Hospital/BSMS<br />

CODE: BSMS/004<br />

F1<br />

F2<br />

Royal Sussex<br />

County Hospital/<br />

Princess Royal<br />

University<br />

Hospital<br />

Royal Sussex<br />

County Hospital/<br />

Princess Royal<br />

University<br />

Hospital<br />

General Internal<br />

Medicine<br />

4m<br />

General Internal<br />

Medicine<br />

4m General Surgery 4m<br />

Nuclear Medicine 4m General Practice 4m Medical<br />

Assessment Unit<br />

4m<br />

Nuclear Medicine comprises the application of radioisotopes for the purposes of medical<br />

diagnosis and therapy. Nuclear Medicine diagnosis frequently entails the production of<br />

images which display the distribution of previously administered radioisotopes within the<br />

body. By focussing on the demonstration of disease through changes in molecular or<br />

www.stfs.org.uk/student/academic-programmes<br />

Email: tfsacademicrecruitment@stfs.org.uk<br />

Page 26 of 70<br />

Updated: 27 May 2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!